The European Commission has on today approved the use of a transdermal patch to deliver medicine to patients with mild-to-moderately severe Alzheimer's disease.
The patch is the first type of transdermal treatment for Alzheimer's disease and is applied once a day to the back, chest or upper arm of patients.
Experts say the patch improves compliance for Alzheimer's patients and also reduces side-effects.
READ MORE @ NURSING IN PRACTICE
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment